In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Endo Pharma buys HealthTronics for $221mm in cash

Executive Summary

Endo Pharmaceuticals Holdings Inc. (mainly neurology and urology drugs) has agreed to buy publicly traded HealthTronics Inc. (urology treatments and anatomical pathology services) for $221mm, plus the assumption of $35mm in debt. Shareholders will receive $4.85 per share (a 41% premium) in cash.
Deal Industry
  • Laboratory Testing Services
  • Medical Devices
  • Medical Devices
    • Laser
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies